chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fever; Nausea; Headache; Severe photosensitivity; This is a spontaneous report from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 19Jan2022 at 16:00 (Lot number: unknown) at the age of 61 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Administration time: 09:00), administration date: 05Mar2021, when the patient was 60 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: UNKNOWN, Anatomical Location: Right arm, Administration time: 09:00), administration date: 01Apr2021, when the patient was 60 years old, for COVID-19 immunisation.  The following information was reported: CHILLS (non-serious) with onset 20Jan2022 at 20:00, outcome "recovering", described as "Chills"; PYREXIA (non-serious) with onset 20Jan2022 at 20:00, outcome "recovering", described as "Fever"; NAUSEA (non-serious) with onset 20Jan2022 at 20:00, outcome "recovering", described as "Nausea"; HEADACHE (non-serious) with onset 20Jan2022 at 20:00, outcome "recovering", described as "Headache"; PHOTOSENSITIVITY REACTION (non-serious) with onset 20Jan2022 at 20:00, outcome "recovering", described as "Severe photosensitivity". Therapeutic measures were not taken as a result of chills, pyrexia, nausea, headache and photosensitivity reaction.  Additional Information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021 at 10:25 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Apr-2021 at 10:25 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 48.38. No concomitant medications were reported. On 28-Apr-2021 at 09:00 A.M., the temperature recorded was 33 degree Fahrenheit and vial was initially moved to the fridge on 19-Apr-2021 and beyond use date was 19-May-2021. Product moved to clinic on 28-Apr-2021.  Vial was stored on cooler 1, on 28-Apr-2021, Excursion duration At 9 AM: 33, 10 AM: 36, 11 AM: 40, 12 AM: 41 1PM: 41, 2 PM : 39, 3 PM: 41, 4 PM: 40.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Pt fell ill after getting both shots in series and never recovered.   the first one  Pfizer bathch  ZP7534 given and two days later pt started to vomit.  could not hold any thing down.  Had to go to Emergency rooms several times for rehdration.    Second  Pfizer Covid shot given  April  12-2021,  Her vomiting escalated. But due to her new illness.  Moved to stay with her sister.    PT Continued to Vomit and  decline in weight from her  140 LBS baseline.  She was admitted to Hospital in July  2021  Told  her esophagus not working and sent home.   She has been told by the doctors that it was her POT smoking causing her vomit.  But she had been smoking POT since age  16, and vomiting had never been an issue untill she took the Phizer shot.     Vomiting continued untill I saw her  Sept 20. At that time  Her weight was down to about  85 LBS and she appeared in near terminal condition.   She did admit to using meth occasionally and recently to gain some measure of strenth as was not able to eat and was starving to death.    She Passed away on October 7th. complications of terminal malnutrition.
This case was reported by a consumer, who was the subject's mother, and described the occurrence of dehydration in a 7-month-old female subject who was vaccinated with Pediarix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent medical conditions included seizure disorder. Concurrently the subject was reported to have also received other "immunization shots" along with Pediarix at 7 months of age (vaccines were unspecified). On an unspecified date the subject received the 1st dose of Pediarix (unspecified dosing). Within 24 hours after vaccination with Pediarix, the subject experienced screaming, refusal to eat and an inability to be consoled. The mother reported that "due to her (daughter's) seizure disorder (they) went to (an) emergency room earlier then (she) usually would." After five hours of screaming, her daughter was admitted to the hospital "only at that point because she was dehydrated from refusing to eat". The subject was hospitalized for tow days. no specified treatment or diagnostic details were provided. There was no mention that the subject experienced seizure. At the time of reporting the outcome of the events were unspecified. The reporter noted about the cause of events that the "pediatrician feels it was the immunization as there were no other symptoms.
Information has been received from a registered nurse concerning a 5th grade female student who on 07/12/1999 was vaccinated with a dose of varicella virus vaccine live.  In mid December 2004 the student developed chickenpox.  According to the school nurse, there were 58 other children in the elementary school who developed chickenpox in mid December 2004 and 34 of the children had previously been vaccinated with a dose of varicella virus vaccine live.  Unspecified medical attention was sought.  There was no information regarding the present status of the 5th grade student.  No product quality complaint was involved.  Additional information has been requested.
I feel like I have COVID right now; Kinda feeling muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (I feel like I have COVID right now) and MYALGIA (Kinda feeling muscle ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced SUSPECTED COVID-19 (I feel like I have COVID right now) and MYALGIA (Kinda feeling muscle ache). At the time of the report, SUSPECTED COVID-19 (I feel like I have COVID right now) and MYALGIA (Kinda feeling muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.    Reporter did not allow further contact
Patient felt nauseous and had a "sharp" headache, patient was instructed to elevate feet and was given a glass of water; patient was monitored closely for 15 minutes post-vaccine, she stated that she felt fine then left. Patient did inform staff that she was anxious about receiving the immunization.
Pneumonia 23 given only 21 days after dose of PREVNAR 13 on 11/28/19 by other provider's office. Patient received Pneumonia 23 at earlier interval than recommended 8 weeks. Merck manufacturer contacted and spoke with Dr. Dr. advised only reaction may be redness/soreness at site but otherwise should not have any system effect. Dr. also did not recommend other vaccination of pneumonia to correct early dose. Only recommended starting pneumonia series again in 4-5 years due to high risk group.
pt recvd 1st dose of Hep B vax on 7MAY92 & on 15MAY92 pt devel t101, aches, pains, diarrhea; several days later, pt recovered;
SKYLINE ICU DOD 5/2/21 VENT REQUIRED14 DAYS, PNEUMONIA, ARDS, HX OF HTN, CAD, THROMBOCYTOPENIA, HYPOCALCEMIA, HX of TIA and Cereb Infarc with resid dysphgagia, Major Depressive Disorder single episode unspecified
Approximately 60 hours after the dose, the patient began feeling stuffy, and had difficulty breathing and swallowing.  She took two diphenhydramine without improvement.  Patient presented to the ED and was treated there for an allergic reaction.  The patient received SoluMedrol 125mg IV and famotidine 20mg by mouth.  Patient began feeling better shortly after the steroid infusion.  Patient was discharged at 2235 and received a prescription for prednisone 40mg for 4 days.
Case number PHHY2013US122311, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 497409) web site on 15 Oct 2013. The report refers to a 38-year-old female patient. Her medical history included drug allergy to BACTRIM, SOMA, melatonin and abnormal response to PAXIL and PROZAC, cerebral palsy and endometriosis. Concomitant drugs included ZOLOFT, LOSEASONIQUE and baclofen. On an unknown date in 2009, the patient received H1N1 (manufacturer and batch number: not reported, so conservatively coded as Pandemic Influenza vaccine INN). On an unknown date, after vaccination she experienced headaches and general weakness with malaise. The outcome of the events was not reported. The seriousness and causality of the events were not reported.
Information has been received from a nurse concerning an around 14 or15 year old female patient who a few month ago, on an unspecified date was vaccinated with a second dose of GARDASIL (Lot # unknown). The nurse reported that after the patient received the second dose of GARDASIL started experiencing syncope that persisted for a few months. According to the nurse, the patient was still experiencing dizziness and lightheadedness. The outcome of the syncopes is unclear. At the time of the report, the patient had not recovered from dizziness and lightheadedness. The patient sought unspecified medical attention. This is one of several reports received from the same source. No further information is available.
Itching and redness at site of injection c/o feeling like face was a little swollen. Denied SOB or Throat swelling/closing
Some arthritis/Arthritis in both hands; The "needle did hurt"; The fingers on her right hand started flexing in the wrong direction/her right middle finger was still uncomfortable; This is a spontaneous report from a contactable consumer (patient) from medical information team. A 72-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EN6205, expiration date was not reported) via intramuscular route, in right arm, on 06Mar2021 11:50 (at the age of 72-year-old) at dose 1, single for covid-19 immunization. Medical history included blood pressure high for a couple years, left knee was bone-on-bone (as reported). There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. No history of previous immunization with the bnt162b2 vaccine and no additional vaccines administered on same date. The patient experienced some arthritis/arthritis in both hands, the vaccine needle going into her arm was uncomfortable, kind of hurt/ needle did hurt, the fingers on her right hand started flexing in the wrong direction/her right middle finger was still uncomfortable on 06Mar2021. The patient underwent lab tests and procedures which included X-ray of left and right hand: arthritis in both hands on 23Mar2021. The events resulted in Physician office visit. No treatment was received for the events. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected
Nausea, dizziness, heart palpitations, abdominal pains, diarrhea, severe headaches, body aches, fatigue
severe body aches (minimal relief from Tylenol) severe headache (no relief from Tylenol) mild fever (101.9) without relief from Tylenol vomiting dizziness Symptoms lasted approximately 30 hours
Information has been received from a physician concerning a patient who was vaccinated with a dose of ZOSTAVAX. On an unknown date, the patient developed shingles. The patient's outcome was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Chronic inflammatory demyelinating polyneuropathy; Information was received from a lawyer regarding a case in litigation concerning a male patient (pt) of unknown age. No information was provided regarding the pt's medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications.  On or about 09-JAN-2013, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported), as recommended for routine health maintenance and for its intended purpose: the prevention of shingles.   On an unspecified date (reported as "shortly after"), the pt was diagnosed with chronic inflammatory demyelinating polyneuropathy. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccination, the pt suffered serious, severe, progressive, permanent and incurable personal injuries that caused physical limitations (physical impairment) not presented prior vaccination; the pt also suffered significant conscious pain and mental anguish, loss of enjoyment of life and emotional distress due to his physical limitations and seriousness of his condition. As a further proximate result, the pt has suffered significant medical expenses, the loss of accumulations and other economic and non-economic damages.  The causality was reported as related and the event was considered to be disabling.   Upon internal review, the pt's chronic inflammatory demyelinating polyneuropathy was determined to be a medically significant event.  Additional information has been requested.
felt like she had a hard area in her stomach; dizzy; stomach was hot like a fire; felt like she had something going on up in her head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL DISCOMFORT (non-serious), outcome "recovered", described as "felt like she had a hard area in her stomach"; DIZZINESS (non-serious), outcome "recovered", described as "dizzy"; DYSPEPSIA (non-serious), outcome "recovered", described as "stomach was hot like a fire"; HEAD DISCOMFORT (non-serious), outcome "recovered", described as "felt like she had something going on up in her head".  Additional Information: Caller has a complaint about Pfizer . She took the COVID vaccine.most like 7 months ago.She has had a headache since her second dose 05Oct2021.Every day since, she has had a headache. She has seen the doctors. Six to seven months is a long time.  She has called before. She saw her primary doctor, and another doctor for the issue with her head. It is not like a normal headache.  gave her a paper after her first dose with an appointment for her second dose.Even the guy asked her health history. She doesn't have a health history.After the first dose , she felt like she had a hard area in her stomach. It was not normal . That started about 5-6 minutes after the first dose. She was dizzy, her stomach was hot like a fire. She sat 15 minutes, and it went away. Then it was gone.But during that time she felt like she had something going on up in her head.Everything was gone 15-20 minutes later.Then, she took the second dose on 05Oct2021.She developed a really weird Headache. It would not leave her alone.She took Tylenol and Advil, and neither made the headache go away. She doesn't have NDC/lot/expiration. She has seen the doctor. Her headache has stayed.The first day after the second dose, she took Advil because she didn't want a headache or fever.She felt the headache 3 days later, and it hasn't stopped since. She is going to go crazy.The doctor has checked her blood work and everything is fine. Description of Product Complaint: Description of complaint:  She took Tylenol and Advil, and neither made the headache go away. She doesn't have NDC/lot/expiration. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This case was reported by a other health professional via sales rep and described the occurrence of chills in a 59-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site pain (1st dose received on 18th June 2018, refer case US2018GSK111832). On 11th October 2018, the patient received the 2nd dose of SHINGRIX. On 12th October 2018, 1 days after receiving SHINGRIX, the patient experienced lightheadedness, injection site pain, injection site bruising, nausea, headache and appetite absent. In October 2018, the patient experienced chills and unwell. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the chills, lightheadedness, injection site pain, injection site bruising, nausea, headache and appetite absent were not recovered/not resolved and the outcome of the unwell was unknown. It was unknown if the reporter considered the chills, lightheadedness, injection site pain, injection site bruising, nausea, headache, appetite absent and unwell to be related to SHINGRIX. Additional details were reported as follows: This case was reported by an office manager. The age at vaccination was not reported. In October 2018, less than a day after vaccination the patient experienced cold chills beginning at 2 am Friday morning. The cold chills lasted through the night until about 6 am. When the patient got up on Friday morning at 6:30 am the patient was lightheaded, the patient's arm was painful at the injection site and it was bruised. Through the day on Friday, the patient felt like the patient was nauseated and had a bad headache. The patient had no appetite, took a long nap and went to bed early. The chills lasted on and off until Saturday morning. The headache lasted until Sunday morning. The patient didn't feel well until Sunday. The patient was feeling good as she did not have to have another dose of SHINGRIX. The patient stated that the received doses were not fun. The patient told her sister each time about her own experience, as she was 65 and would like to also have the vaccine. But she said the patient was not a walking advertisement for getting the injection and although she was having second thoughts, she still wanted to go forward with it. This case has been linked with US2018GSK195620, reported by same reporter.
After third COVID booster shot, I initially had no reaction just like the first two previous doses except for sore arm, little tiredness.  5 days later I got a rash and swelling/inflammation on both my ankles.  I reached out to my rheumatologist as I had stopped my RA medication this time and reported it and she didn't think vaccine caused it.  On Day 9, I awoke with sudden complete hearing loss in right ear and left ear sounded like freight train/jet in my head.  I immediately went to Urgent Care and was put on prednisone.  I followed up with three doctors (Audiologist, ENT, and rheumatologist).  Hearing was restored next day but pain in ear, muscle spasms, headaches, dizziness still occured.    One doctor thinks it is vaccine related and that I was off my RA medication and I have weakened immunity system but other doctor thought it was a coincidence.  I wanted to report this to you!!  I am still on prednisone and will have CT scan of my sinuses next week if still not resolved.  Very scary!!
reported having only pain in back and pain in joints; reported having only pain in back and pain in joints; fever; vomiting; no appetite; can't eat; strong cough or expectoration; started to feel bad also; she was too weak; This is a spontaneous report from a contactable consumer. This 56-year-old female consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received the first dose of the Pfizer-BioNTech COVID-19 Vaccine. Patient asked if it would be okay to get the second dose, will it be worse on the 2nd dose, I had a side effect after the first dose of the vaccine. Should I get the second dose. Patient mentioned that she was okay after 7 days, reported having only pain in back and pain in joints. Patient mentioned her husband was not feeling well initially, and afterwards, patient started to feel bad also. After 10-11 days after the vaccine, patient reported to have a fever, vomiting, no appetite; can't eat, and a strong cough or expectoration. patient asked if these were possible side effects of this vaccine, offered to transfer to safety, but patient declined, mentioned she was too weak to do that right now. The outcome of the events was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Hive type red masks on head first, then face, then chest and finally at thigh. Sight where Comvax was given. Please see enclosed dietician.